RRS® HA Cellutrix (1x10ml)
The lowest price of the product zł69.00 in day 31.01.2026
Lowest price in the last 30 days: zł69.00
RRS® HA Cellutrix is a sterile Class III medical device designed for the injectable therapy of subcutaneous tissue and the dermis in areas affected by lipodystrophy (cellulite) and localized fat accumulation. The preparation combines low-concentration non-cross-linked hyaluronic acid with an extensive biorevitalizing complex that activates lipolytic processes and improves microcirculation. The device acts as a structural modulator of the extracellular matrix, reducing tissue irregularities and improving the biomechanical parameters of the skin.
Mechanism of Action
-
lipolysis and metabolism stimulation (caffeine and fucoxanthin): the included lipolytic ingredients activate beta-adrenergic receptors in adipocytes, initiating the breakdown of triglycerides into free fatty acids and glycerol, leading to a mechanical reduction of subcutaneous fat volume
-
transport and drainage optimization (ahas): glycolic and lactic acids (ahas) act as diffusion promoters for active substances and stimulate the removal of metabolic waste from the intercellular spaces, reducing edema associated with cellulite
-
structural ecm reorganization (ha): non-cross-linked hyaluronic acid provides an optimal hydrodynamic environment for fibroblasts, restoring proper skin turgor and neutralizing the "orange peel" effect
-
antioxidant protection and vascular reinforcement (flavonoids, polyphenols, vitamins): a rich complex of protective ingredients seals capillaries and neutralizes free radicals, which improves tissue trophicity and prevents fibrosis within the connective tissue
-
saponin-terpene revitalization: stimulates lymphatic and venous circulation, which is critical in the treatment of aqueous and fibrous cellulite
Indications and Intended Use
The device is intended for implantation by authorized medical personnel to:
-
cellulite reduction: smoothing structural irregularities on the skin surface
-
body contouring: localized reduction of fat deposits (localized fat corrector)
-
biostimulation of hypotonic areas: improving the density and elasticity of the skin on the buttocks, abdomen, and thighs
-
improvement of tissue microcirculation: detoxification and nourishment of areas affected by lymphatic stasis
Application Areas
-
buttocks
-
thighs (posterior and lateral sides)
-
abdomen
Composition
-
hyaluronic acid: 0.05 mg/ml (in a 17.5 mg/ml biorevitalizing solution)
-
biorevitalizing complex: 8 antioxidants, 2 lipolytics (caffeine, fucoxanthin), 7 flavonoids, 8 microelements, 3 vitamins, 8 saponins, 3 triterpenes, 1 amino acid, 2 ahas, 2 polyphenols
-
buffer: phosphate q.s.
Technical Information and Protocol
-
form: 10 ml vial
-
application site: subcutaneous tissue / deep layer of the dermis
-
implementation technique: needle mesotherapy (deposit, nappage)
-
recommended combined therapy: can be used with organic silica (silisorg) in a 1:1 ratio to intensify the firming effect
-
treatment cycle (induction phase): a series of 3–4 treatments at 3–4 week intervals
-
effect prognosis: first structural changes visible approximately 14–21 days after the first treatment
-
package contents: 1 vial 10 ml
|
VIAL |
||
|
STERILE |
||
|
Product to be used only by doctors or cosmetologists trained in aesthetic medicine. |
||